Doctor profile · Federal record
Dr. Regina Dodis, D. O.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Greenville, NC
- NPI 1649297722
- Accepts Medicare
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1006 Wh Smith Blvd
Greenville, NC 278345194
(252) 413-6683
fax (252) 413-6603 - Mailing address
-
1850 W Arlington Blvd
Greenville, NC 278345704
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- June 29, 2015
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Connecticut #044491
- Medicaid
- CT #001444918
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649297722. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,215
Distinct HCPCS
10
Medicare allowed
$321,270
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 4,803 | 55 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 764 | 408 | $122 | |
83036 |
Hemoglobin a1c level | 532 | 259 | $9 | |
36415 |
Insertion of needle into vein for collection of blood sample | 424 | 267 | $8 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 386 | 212 | $3 | |
99457 |
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 351 | 54 | $46 | |
99458 |
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 343 | 50 | $38 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 313 | 209 | $16 | |
84439 |
Thyroxine (thyroid chemical), free | 280 | 189 | $9 | |
84481 |
Thyroid hormone, t3 measurement, free | 251 | 166 | $16 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 312. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$954
Transactions
47
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Insulet Corporation | 2 | $173.19 | |
| Amgen Inc. | 10 | $157.41 | |
| Abbott Laboratories | 18 | $153.26 | |
| CeQur Corporation | 1 | $113.73 | |
| Dexcom, Inc. | 2 | $102.43 | |
| Lilly USA, LLC | 4 | $68.39 | |
| Corcept Therapeutics | 3 | $58.63 | |
| Medtronic, Inc. | 2 | $48.83 | |
| Novo Nordisk Inc | 3 | $46.02 | |
| Ascensia Diabetes Care Us Inc. | 1 | $17.70 | |
| RECORDATI_RARE_DISEASES_INC. | 1 | $14.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,601
Patients
596
Total drug cost
$1,163,065
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 558 | 124 | $8,008 |
| Ozempic (Semaglutide) | Brand | 315 | 60 | $394,415 |
| Synthroid (Levothyroxine Sodium) | Brand | 283 | 51 | $22,024 |
| Methimazole | Generic | 216 | 49 | $2,692 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 170 | 35 | $116,454 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 136 | 25 | $111,005 |
| Glipizide Er (Glipizide) | Brand | 121 | 28 | $3,594 |
| Gabapentin | Generic | 120 | 30 | $3,447 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 113 | 30 | $1,548 |
| Novolog Flexpen (Insulin Aspart) | Brand | 106 | 35 | $161,946 |
Frequently asked questions
What is Dr. Regina Dodis's medical specialty?
Dr. Regina Dodis practices Endocrinology, Diabetes & Metabolism Physician in Greenville, NC.
Where does Dr. Regina Dodis practice?
Dr. Regina Dodis practices at 1006 Wh Smith Blvd, Greenville, NC 278345194. Office phone: 2524136683.
What is Dr. Regina Dodis's NPI?
Dr. Regina Dodis's National Provider Identifier (NPI) is 1649297722, issued by NPPES.
Does Dr. Regina Dodis accept Medicare assignment?
Yes. Dr. Regina Dodis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Regina Dodis commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036). Source: CMS Medicare Physician & Other Practitioners file.